The compound "Recombinant Lactobacillus plantarum Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)" refers to a genetically engineered form of the bacterium Lactobacillus plantarum that produces the protein Gcp. Lactobacillus plantarum is a common bacterium found in fermented foods and the gastrointestinal tracts of humans and animals, known for its probiotic properties . The "Gcp" protein, or "Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp," is involved in the biosynthesis of a modified nucleoside found in tRNA (transfer RNA) .
Gcp is involved in tRNA modification, specifically in the biosynthesis of threonylcarbamoyladenosine, a modified nucleoside found in tRNA . Transfer RNA (tRNA) is essential for protein synthesis, as it decodes mRNA sequences to synthesize proteins. Modifications to tRNA, such as the addition of chemical groups, can affect the efficiency and accuracy of translation .
Creating a recombinant Lactobacillus plantarum strain involves introducing a gene encoding the Gcp protein into the bacterium's genome . This is often done to enhance the production of Gcp or to use Lactobacillus plantarum as a vehicle for delivering Gcp for therapeutic or industrial purposes .
Probiotic Applications: Recombinant Lactobacillus plantarum can be used to modulate the gut microbiota and improve gut health. For example, surface-displayed FomA in L. plantarum amplified the immune reaction of B cells and CD4+T cells, and induced secretion of cytokines .
Vaccine Development: Recombinant Lactobacillus plantarum has been explored as a vaccine delivery system. For instance, it can be engineered to express specific antigens, stimulating an immune response in the host .
Antimicrobial Production: L. plantarum produces various metabolites, including antimicrobial compounds, which can be enhanced through genetic modification .
Metabolic Engineering: By modifying Lactobacillus plantarum, researchers can enhance its ability to produce valuable metabolites or degrade specific compounds. Comparative transcriptional analysis has revealed metabolic and regulatory mechanisms of GOS utilization by L. plantarum .
Membrane Protein Production: L. plantarum can be used as a platform for the production and purification of membrane proteins such as RseP, which is involved in bacterial stress response and virulence .
Therapeutic Protein Delivery: Recombinant L. plantarum can deliver therapeutic proteins to the host. For example, a recombinant L. plantarum strain expressing the spike protein of SARS-CoV-2 has been developed .
Oral Immunization: Recombinant L. plantarum can be used for oral immunization in animals. For example, a recombinant L. plantarum expressing the pgsA-gp85 gene was shown to trigger specific antibodies against avian leukosis virus subgroup J (ALV-J) in chickens .
Lactobacillus plantarum has versatile applications, supported by various research findings:
Immune Modulation: Recombinant L. plantarum strains can modulate immune responses. Feeding mice with recombinant L. plantarum resulted in significant changes in immune cell activation and cytokine secretion, suggesting its potential in regulating inflammatory responses .
Antimicrobial Activity: Metabolomic analysis of L. plantarum strains has identified key metabolites, such as amino acids, nucleotides, and organic acids, associated with antimicrobial activity .
Metabolic Pathways: Transcriptomic studies have revealed the metabolic pathways involved in the utilization of prebiotic compounds like galactooligosaccharides (GOS) by L. plantarum .
Vaccine Delivery: Recombinant L. plantarum can effectively deliver antigens and induce specific antibody responses, demonstrating its potential as a vaccine delivery system .
Production of Membrane Proteins: L. plantarum can be used for the production and purification of integral membrane proteins, expanding its applications in biotechnology .
| Cytokine | Experimental Group | Control Group | p-value |
|---|---|---|---|
| IL13 | Increased | Baseline | < 0.05 |
| IgG | Higher | Lower | < 0.01 |
| IgA | Higher | Lower | < 0.01 |
| IL17 | Lower | Higher | < 0.05 |
| IL22 | Lower | Higher | < 0.05 |
| TNFα | Lower | Higher | < 0.05 |
This data suggests that recombinant L. plantarum modulates the immune response, increasing anti-inflammatory cytokines (IL13, IgG, IgA) and decreasing pro-inflammatory cytokines (IL17, IL22, TNFα) .
| Metabolite | Category | Potential Activity |
|---|---|---|
| 4-Hydroxyphenyllactic acid | Organic Acid | Antimicrobial |
| Benzoic Acid | Organic Acid | Antimicrobial |
| Lauric Acid | Fatty Acid | Antimicrobial |
| Val-Leu-Pro-Val-Pro-Gln | Oligopeptide | Antimicrobial, Probiotic |
This table illustrates metabolites identified in L. plantarum UTNGt2, highlighting their potential antimicrobial and probiotic activities .
This figure shows the PCR amplification of the gp85 gene from the pMD18T-env recombinant vector (expected size 930 bp) (A) and the amplification of the pgsA gene from the T7-pgsBCA recombinant vector (expected size 1,143 bp) (B) .
This protein is essential for the formation of a threonylcarbamoyl group at adenosine 37 (t6A37) in tRNAs recognizing codons starting with adenine. It participates in transferring the threonylcarbamoyl moiety from threonylcarbamoyl-AMP (TC-AMP) to the N6 group of A37, collaborating with TsaE and TsaB. TsaD likely plays a direct catalytic role in this reaction.
KEGG: lpl:lp_0721
STRING: 220668.lp_0721
Threonylcarbamoyladenosine (t6A) is a modified nucleoside universally conserved in tRNAs across all three kingdoms of life. This modification is located in the anticodon stem-loop at position 37 adjacent to the anticodon of tRNAs and is found in nearly all tRNAs that decode ANN codons .
The significance of t6A lies in its role as a critical component of the translation apparatus. It maintains translation accuracy by ensuring proper codon recognition during protein synthesis. In bacteria specifically, t6A functions as a strong positive determinant for aminoacylation of tRNA by bacterial-type isoleucyl-tRNA synthetases and might also serve as a determinant for the essential enzyme tRNA Ile-lysidine synthetase .
The t6A biosynthesis pathway shows both universal components and kingdom-specific variations:
Universal core enzymes: Two core enzyme families are required for t6A synthesis in all domains of life .
Bacterial pathway: In bacteria, the t6A synthesis pathway involves the TsaB, TsaC, TsaD, and TsaE proteins (previously known as YeaZ, YrdC, YgjD, and YjeE respectively) .
Eukaryotic/archaeal pathway: These organisms have their own set of t6A biosynthesis enzymes distinct from bacteria .
Mitochondrial pathway: Specialized t6A biosynthesis machinery exists for mitochondrial tRNAs .
The bacterial pathway specifically involves the formation of threonylcarbamoyl-adenylate (TC-AMP) as an intermediate, activated for condensation with adenosine-37 of tRNA .
Recombinant L. plantarum protein expression typically follows these methodological steps:
Construction of expression vector: The gene encoding the target protein is cloned into an appropriate expression vector, often with a fusion tag for purification .
Expression conditions: Recombinant L. plantarum is cultured and induced as described in previous protocols. Typically, 1 × 10^6 CFU of bacteria are washed, followed by the addition of 1 mL of 1% BSA in PBS and incubation for 1 hour .
Protein verification: Expression can be verified through:
Purification: The recombinant protein is typically purified using affinity chromatography based on the fusion tag included in the construct, followed by size exclusion chromatography if needed.
Quality control: Purity assessment is performed using SDS-PAGE (>85% purity is typically desired) .
For optimal stability and activity retention of recombinant tRNA threonylcarbamoyladenosine biosynthesis protein:
Temperature: Store at -20°C/-80°C
Form considerations:
Liquid form: shelf life of approximately 6 months
Lyophilized form: shelf life of approximately 12 months
Reconstitution: Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Glycerol addition: Add 5-50% of glycerol (final concentration) and aliquot for long-term storage
Working aliquots: Store at 4°C for up to one week
Freeze-thaw cycles: Repeated freezing and thawing is not recommended
The essentiality of t6A biosynthesis shows interesting patterns across bacterial species:
Essential in most prokaryotes: Genome-wide essentiality studies demonstrate that genes for t6A synthesis are critical for survival in most bacterial species .
Species with non-essential t6A: Interestingly, t6A is dispensable in specific bacteria including:
Molecular basis for essentiality: In organisms where t6A is essential, the molecular mechanism appears related to:
The proteomics analysis of t6A-deficient D. radiodurans strains revealed an induction of the proteotoxic stress response, suggesting that while some bacteria can survive without t6A, they experience significant translational stress that must be compensated through alternative mechanisms .
Several sophisticated methodological approaches can assess the impact of t6A modification on translation:
Ribosome profiling analysis: This technique can reveal codon-specific changes in ribosome occupancy resulting from t6A deficiency, particularly at elevated temperatures relevant to host environments (37°C) .
Dual-reporter assay system: This approach can be used to examine the role of t6A modifications in specific codon decoding:
Two sets of consecutive codons (e.g., AUA or AUC) are inserted at the beginning of a reporter gene (GFP)
A second reporter (e.g., mCherry) serves as an internal control
The decoding efficiency is evaluated by measuring normalized GFP signals
This approach was successfully used to demonstrate the role of tRNA modifications in AUA decoding
LC-MS analysis of tRNA modifications: Liquid chromatography-mass spectrometry can be used to detect and quantify t6A modifications in tRNA preparations from L. plantarum under different conditions. Co-injection analyses of nucleosides from different sources can confirm the identity of specific modifications .
Translation efficiency assays: In vitro translation systems using purified components can directly assess the impact of t6A-modified versus unmodified tRNAs on translation rates and accuracy.
The t6A modification pathway in L. plantarum and other bacteria follows these key biochemical steps:
Formation of TC-AMP intermediate: The TsaC protein (YrdC ortholog) catalyzes the formation of threonylcarbamoyl-adenylate (TC-AMP) .
ATP utilization pattern: This process involves:
Mechanistic details: The pathway proceeds through:
Notable distinctions in L. plantarum include:
Unlike some bacteria, L. plantarum lacks the capacity to synthesize either flavins or quinones, relying on exogenous sources
This metabolic dependency affects the organism's redox balance and potentially influences the activity of enzymes involved in tRNA modification
Genetic manipulation approaches to study t6A's role in L. plantarum include:
Gene deletion/knockout strategies:
Conditional expression systems:
Complementation experiments:
Phenotypic assessment methods:
Temperature significantly impacts t6A modification in bacteria with important implications for host-pathogen interactions:
Temperature-dependent ribosome occupancy: Ribosome profiling analyses reveal that t6A modification deficiency alters ribosome occupancy patterns particularly at 37°C—the body temperature of human hosts .
Growth temperature effects:
Bacteria with t6A deficiencies often show temperature-sensitive growth phenotypes
This suggests the modification may be particularly important for translation accuracy at elevated temperatures
Adaptation to host environments:
Experimental approaches to study temperature effects:
Comparative growth assays at different temperatures (25°C, 30°C, 37°C, 42°C)
Analysis of t6A levels at different temperatures using LC-MS
Measurement of translation error rates at different temperatures using reporter systems
The t6A modification in L. plantarum may significantly impact immune interactions based on related research:
Dendritic cell activation: Recombinant L. plantarum expressing modified proteins can activate dendritic cells in Peyer's patches (PPs) of mice, as evidenced by increased expression of activation markers:
T-cell responses: Recombinant L. plantarum can induce:
B-cell activation and antibody production:
Application considerations:
Probiotics delivery of recombinant proteins may depend on proper tRNA modification for accurate translation
t6A modification could affect the stability and immunogenicity of recombinant proteins
Understanding the role of t6A could lead to improved vaccine delivery systems using L. plantarum as a vector
Multiple complementary techniques can verify the function and activity of recombinant Gcp protein:
In vitro t6A formation assay:
Complementation assays:
ATP hydrolysis assay:
Protein-protein interaction studies:
Structural validation:
Circular dichroism to confirm proper protein folding
Limited proteolysis to assess structural integrity
Thermal shift assays to evaluate protein stability
Efficient strategies for generating and validating modified L. plantarum strains include:
Strain generation methods:
Verification of genetic modifications:
Functional validation:
Controls and standards:
Include wild-type strains in all experiments
Use complemented mutants to confirm phenotype specificity
Include bacterial strains with known t6A modification defects as references
Implement appropriate statistical analyses for reproducibility assessment
Designing robust experiments to investigate t6A's role in translation accuracy requires:
Reporter system design:
Codon bias considerations:
Analyze L. plantarum genome for codon usage patterns
Focus on ANN codons, particularly those that might be affected by t6A
Construct reporter systems with varying frequencies of target codons
Quantification methods:
Flow cytometry for single-cell analysis of reporter expression
Plate reader assays for high-throughput screening
Western blotting for protein level confirmation
RT-qPCR for mRNA level normalization
Experimental controls:
Advanced analytical approaches:
Ribosome profiling to identify codon-specific translation pauses
Mass spectrometry to identify mistranslation events
In vitro translation systems with purified components
Comprehensive understanding of t6A modification in L. plantarum requires interdisciplinary approaches:
Structural biology:
X-ray crystallography or cryo-EM of Gcp protein structures
Structure-function relationships through targeted mutagenesis
Molecular dynamics simulations of tRNA-enzyme interactions
Systems biology:
Multi-omics integration (transcriptomics, proteomics, metabolomics)
Network analysis of genes affected by t6A deficiency
Mathematical modeling of translation dynamics
Evolutionary biology:
Comparative genomics across Lactobacillus species
Phylogenetic analysis of t6A pathway components
Investigation of selective pressures on tRNA modification systems
Microbial ecology:
Host-microbe interactions:
Synthetic biology:
Design of engineered strains with optimized t6A modification systems
Creation of synthetic tRNA modification pathways
Development of biosensors for monitoring tRNA modification states
Distinguishing direct from secondary effects in t6A research requires sophisticated experimental design:
Temporal analysis approaches:
Time-course experiments following t6A depletion
Early timepoints capture direct effects before compensatory responses
Integration of multi-omics data at different timepoints
Conditional expression systems:
Specific codon reporter systems:
Combined genomic/biochemical approaches:
Genetic suppressor screens:
Identify mutations that alleviate t6A deficiency phenotypes
Suppressors often point to primary defects or compensation mechanisms
Complementation with related tRNA modification systems
In vitro reconstitution:
Purified translation systems with defined components
Direct assessment of t6A effects on decoding without cellular adaptations
Comparison of in vitro and in vivo results to identify secondary effects